Annual Secretarial Compliance Report for the year ended 31st March, 2025
Compliances-Reg.24(A)-Annual Secretarial Compliance
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Titan Biotech Limited on 6ix
Earlier from Titan Biotech
- Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31, 2025 And Consideration Of Recommendation Of Final Dividend, If Any For The Financial
- Titan Biotech Limited Press Release Mar 25 2025
- Closure of Trading Window
- Titan Biotech Limited Press Release Feb 28 2025
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
Later from Titan Biotech
- Board Meeting Outcome for Outcome Of Board Meeting
- Results_Audited Financial Results For The Quarter And Year Ended March 31, 2025
- Appointment Of Secretarial Auditor
- Appointment Of Cost Auditor
- Appointment Of Internal Auditor
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech